< Back to Portfolio

NanoCellect

Next gen cell-sorting technology

  • company-website-icon
  • company-linkedin-icon
  • company-twitter-icon

About

NanoCellect empowers scientists to make discoveries one cell at a time, by ensuring high cell viability for advance cell-based research. The company develops and delivers microfluidic based solutions that are affordable, compact, and easy-to-use and enable biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, antibody discovery, and basic research.

  • Location: San Diego, CA
  • Paladin Initial Investment Date: June 2023

Portfolio Stats

Over 75 Companies

Paladin has invested in over 75 portfolio companies since 2001.

4 Continents

Paladin has invested in companies in North America, Australia, Europe, and South America.

Over $2 billion

Paladin was founded in 2001 and has since managed over $2B of companies and assets.